Short Description

This panel aids in prognostication and therapeutic decisions for Lung carcinoma where mutation has been demonstrated in MET, BRAF, EGFR, ERBB2 and KRAS and copy number variations in ALK1, ROS1 and MET. PD-L1 22C3 assay is indicated as a Companion Diagnostic aid in identifying patients for the treatment with KEYTRUDA (Pembrolizumab) therapy. It also enables the screening of clinically actionable targets for personalized targeted medicine in Lung adenocarcinom

PreTest Information

Provide a copy of the Histopathology report, Site of biopsy and Clinical history. Duly filled NGS Test Requisition Form (Form 40) is mandatory.

Detail Description

Cancer Targeted Gene Panel: Lung with PDL-1 (DAKO) Test Cost INR 35000

Cancer is a dreaded disease that affects millions of people worldwide. It is caused due to the uncontrolled growth of abnormal cells in the body. Lung cancer is one of the most common types of cancer, and it can be caused due to a variety of factors such as smoking, exposure to certain chemicals, and environmental pollutants. Early detection and treatment of lung cancer can significantly improve the chances of survival. One of the most advanced diagnostic tests for lung cancer is the Cancer Targeted Gene Panel: Lung with PDL-1 (DAKO) test.

Symptoms of Lung Cancer

The symptoms of lung cancer can vary depending on the stage of the disease. In the early stages, there may be no symptoms, and the cancer may be detected during routine medical checkups. However, as the disease progresses, the following symptoms may appear:

• Cough that doesn't go away
• Chest pain
• Shortness of breath
• Wheezing
• Hoarseness
• Unexplained weight loss
• Coughing up blood

Diagnosis of Lung Cancer

The diagnosis of lung cancer involves a series of tests and procedures. The first step is usually a physical examination to check for any signs of lung cancer. This is followed by imaging tests such as X-rays, CT scans, and MRI scans to get detailed images of the lungs. If any abnormalities are detected, a biopsy may be performed to confirm the presence of cancerous cells.

Cancer Targeted Gene Panel: Lung with PDL-1 (DAKO) Test

The Cancer Targeted Gene Panel: Lung with PDL-1 (DAKO) test is a highly advanced diagnostic test that can detect lung cancer at an early stage. This test uses cutting-edge technology to analyze the DNA of cancer cells and identify specific genetic mutations that are associated with lung cancer. The test also measures the levels of the PDL-1 protein, which is an important biomarker for lung cancer.

Test Cost

The cost of the Cancer Targeted Gene Panel: Lung with PDL-1 (DAKO) test in India is INR 35000. This may vary depending on the location and the diagnostic center where the test is performed. However, it is important to note that this test is highly accurate and can significantly improve the chances of early diagnosis and treatment of lung cancer.

Conclusion

The Cancer Targeted Gene Panel: Lung with PDL-1 (DAKO) test is a highly advanced diagnostic test that can detect lung cancer at an early stage. This test can help in the early detection and treatment of lung cancer, which can significantly improve the chances of survival. The cost of the test may vary, but it is a small price to pay for the benefits that it offers. If you have any symptoms of lung cancer or are at a high risk of developing the disease, it is recommended to consult a doctor and get tested.

At DNA Labs India, we offer a wide range of diagnostic tests for various types of cancer, including the Cancer Targeted Gene Panel: Lung with PDL-1 (DAKO) test. Our tests are highly accurate and reliable, and we use the latest technology to ensure fast and accurate results. Contact us today to schedule an appointment and get tested.